Asparagine
Asparagine is the amide of aspartic acid: the same length of side chain, with the charge replaced by a neutral carboxamide. It is the attachment point for N-linked sugars, and one of the least stable residues in a stored peptide.
- Molecular formula
- C4H8N2O3
- Molar mass
- 132.12 g/mol
- Residue mass, average
- 114.1038 Da
- Residue mass, monoisotopic
- 114.04293 Da
- pKa (α-COOH / α-NH₃⁺)
- 2.02 / 8.8
- Isoelectric point
- 5.41
- CAS number
- 70-47-3
Structure
- H
- C
- N
- O
- S
The 3D geometry represents the neutral experimental record; the pH control applies to the skeletal view.
The skeletal view begins with the zwitterion at pH 7.
An amide, not an acid
Replacing the −OH of aspartic acid with −NH₂ removes the charge entirely. What remains is a strong hydrogen-bond donor and acceptor that stays neutral across the whole pH range.
Short reach
Only one methylene group separates the amide from the backbone. That short arm is what makes asparagine prone to attacking its own backbone, which is the root of its stability problems.
Charge and pH
No third step
The carboxamide does not ionise, so asparagine titrates like alanine or glycine: two steps and an isoelectric point between the two pKa values.
A low pI for a neutral residue
Asparagine’s isoelectric point, 5.41, is lower than most neutral residues because the nearby amide makes its alpha carboxyl slightly more acidic. It still contributes no charge in a peptide.
Properties
| IUPAC name | (2S)-2,4-diamino-4-oxobutanoic acid |
|---|---|
| Three-letter code | Asn |
| One-letter code | N |
| Class | Polar, uncharged |
| Dietary requirement | Non-essential |
| CAS | 70-47-3 |
| PubChem CID | 6267 |
| InChIKey | DCXYFEDJOCDNAF-REOHCLBHSA-N |
| Formula | C4H8N2O3 |
|---|---|
| Molar mass | 132.12 g/mol |
| Residue mass, average | 114.1038 Da |
| Residue mass, monoisotopic | 114.04293 Da |
| Side chain | Carboxamide |
| pKa, α-carboxyl | 2.02 |
| pKa, α-amino | 8.8 |
| Isoelectric point | 5.41 |
| Hydropathy | -3.5 |
| Volume ų | 96 |
Genetic code and occurrence
Codons
- AAU
- AAC
Codons are written as mRNA; U is uracil.
| Frequency in proteins | 4.06% |
|---|---|
| Number of codons | 2 |
| Dietary requirement | Non-essential |
Role in peptides
The glycosylation sequon
N-linked sugars attach to asparagine, but only when the sequence reads Asn-X-Ser or Asn-X-Thr, with X as anything except proline. That three-residue pattern is one of the most recognisable motifs in protein science.
The deamidation hot spot
Asparagine followed by glycine deamidates fastest of all, because the small neighbour leaves room for the side chain to cyclise onto the backbone.
Capping helices
Asparagine is common at the first turn of an alpha helix, where its side chain can hydrogen bond to backbone groups that have no partner of their own.
Compounds containing this residue
No asparagine: BPC-157, DSIP, Epitalon, KPV, MOTS-c, Pinealon, Selank, Semax.
Biological role
Made from aspartate
Asparagine synthetase adds an amide group to aspartate using glutamine as the nitrogen donor. The reaction is straightforward and asparagine is classed as non-essential.
A cancer treatment target
Some leukaemia cells cannot make enough asparagine themselves. The enzyme asparaginase, which destroys circulating asparagine, has been part of childhood leukaemia treatment for decades.
Where the name came from
Asparagine was the first amino acid isolated, from asparagus juice in 1806, which is also where it takes its name.
Deamidation as a clock
The slow conversion of asparagine to aspartate happens in living tissue too, and has been proposed as one of the molecular timers behind protein ageing in long-lived proteins such as lens crystallins.
Research evidence
| Area | Summary | Evidence |
|---|---|---|
| Asparaginase in leukaemia | Depleting circulating asparagine is established treatment in certain leukaemias. This is a licensed medicine used under specialist care, not a nutritional finding. | Established |
| Dietary asparagine and cancer spread | Preclinical work has reported that restricting asparagine slows metastasis in mouse models of breast cancer. Whether dietary restriction does anything comparable in people has not been tested. | Preclinical |
| Asparagine as a supplement | There is essentially no human trial literature on supplemental asparagine, and no described deficiency in people eating enough protein. | Not studied |
These summaries describe research on amino acids and related molecules, not evidence for Aminos products. Aminos products are laboratory research reagents, not supplements or medicines.
Laboratory notes
The main stability liability
Asparagine deamidates to aspartate and isoaspartate, especially at neutral to slightly alkaline pH and at raised temperature. The mass change is only +0.98 Da, small enough to be missed if a method is not looking for it.
Asn-Gly is the worst case
If a sequence contains Asn-Gly, that is the first place to look when a peptide loses activity in storage. Lower pH and lower temperature both slow the reaction.
Side-chain protection
Unprotected asparagine can dehydrate to a nitrile during activation, so the amide is usually protected during solid-phase synthesis.
Does not absorb at 280 nm
Asparagine adds nothing to absorbance at 280 nm, so concentration must come from a Trp or Tyr elsewhere in the sequence.
References
Sources used for the data on this page.
- PubChem CID 6267: L-AsparagineIdentifiers, formula and physical data.
- pKa and pI values for the twenty amino acidsDepartment of Chemistry, University of Calgary.
Reference information only. This page describes the chemistry and biology of an amino acid. Nothing here is medical, nutritional or dosing advice. Aminos compounds are sold strictly for laboratory research use and are not medicines.